SLC25A24 and thyroid gland carcinoma: SLC25A24 mutation showed the highest HR in breast invasive cancer among all SLC25 genes, and it also showed certain risk effects in mesothelioma, ovarian serous cystadenocarcinoma, and thyroid carcinoma.